Urman Bulent, Yakin Kayhan, Balaban Basak
Assisted Reproduction Unit, American Hospital of Istanbul, Turkey.
Reprod Biomed Online. 2005 Sep;11(3):382-91. doi: 10.1016/s1472-6483(10)60847-4.
The success of assisted reproduction, although gradually increasing over the years, is still less than satisfactory. Many couples have benefited from this treatment; however, many have also been left frustrated following multiple failed attempts. Couples who fail to conceive after multiple IVF/intracytoplasmic sperm injection (ICSI) treatments often seek treatment options that are new and that have not been offered before. Some of these include immunological testing and treatment, allogenic lymphocyte therapy, intratubal transfer of zygotes and embryos, blastocyst transfer, sequential embryo transfer, assisted hatching, co-cultures, and preimplantation genetic screening for aneuploidy. Although the evidence behind some of these is more robust, most suffer from lack of well designed randomized trials comparing them with other treatment options. Randomized studies are extremely difficult to conduct, as couples will resist being randomized into a treatment group where previously failed procedures will be repeated. In the mean time, assisted reproduction programmes should resist offering treatment options that are not evidence based, or at least they should share with the couple the information that is available and should stress that none of these is a panacea for their problem.
辅助生殖技术虽然这些年来成功率在逐步提高,但仍不尽如人意。许多夫妇从这种治疗中受益;然而,也有许多夫妇在多次尝试失败后感到沮丧。经过多次体外受精/卵胞浆内单精子注射(ICSI)治疗仍未能受孕的夫妇,常常寻求未曾提供过的新治疗方案。其中一些方案包括免疫检测与治疗、同种异体淋巴细胞疗法、输卵管内受精卵和胚胎移植、囊胚移植、序贯胚胎移植、辅助孵化、共培养以及非整倍体植入前基因筛查。尽管其中一些方案背后的证据更为充分,但大多数都缺乏与其他治疗方案进行比较的精心设计的随机试验。进行随机研究极其困难,因为夫妇们会抗拒被随机分配到一个会重复之前失败程序的治疗组。与此同时,辅助生殖项目应避免提供没有循证依据的治疗方案,或者至少应与夫妇分享现有信息,并强调这些方案都不是解决他们问题的万灵药。